Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
제품번호 | 종 | 제품 설명 | 구조 | 순도 | 특징 |
---|---|---|---|---|---|
IL3-H52G3 | Human | Human IL-13 Protein, GST Tag |
|
||
IL3-C5249 | Cynomolgus | Cynomolgus IL-13 Protein, His Tag (MALS verified) |
|
||
IL3-M5249 | Mouse | Mouse IL-13 Protein, His Tag |
|
||
IL3-C52H4 | Canine | Canine IL-13 Protein, His Tag |
|
||
IL3-H82E5 | Human | Biotinylated Human IL-13 Protein, His,Avitag™ (MALS verified) |
|
||
IL3-H5256 | Human | Human IL-13 Protein, Fc Tag |
|
||
IL3-H52H4 | Human | Human IL-13 Protein, His Tag |
|
Biotinylated Human IL-13 R alpha 1 Protein, His,Avitag (Cat. No. IL1-H82E8) captured on Biotin CAP-Series S Sensor Chip can bind Human IL-13 Protein, His Tag (Cat. No. IL3-H52H4) with an affinity constant of 34.4 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Tralokinumab | BAK-502G9; CAT-354 | Approved | Medimmune Llc | Adtralza, ADBRY | United States | Dermatitis, Atopic | Leo Pharma A/S | 2021-06-17 | Idiopathic Pulmonary Fibrosis; Asthma; Colitis, Ulcerative; Dermatitis, Atopic | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Dectrekumab/VAK-694 | QBX-258 | Phase 2 Clinical | Novartis Pharma Ag | Lymphedema; Asthma | Details |
SAR-443726 | SAR-443726 | Phase 1 Clinical | Sanofi | Dermatitis, Atopic | Details |
SAR-443765 | SAR-443765 | Phase 1 Clinical | Sanofi | Inflammation | Details |
AIR-645 | AIR-645; ISIS-369645 | Ionis Pharmaceuticals Inc | Details | ||
Romilkimab | SUB-33159; SAR-156597 | Sanofi | Details | ||
GSK-2434735 | GSK-2434735 | Glaxosmithkline Plc | Details | ||
AMG-317 | AMG-317 | Amgen Inc | Details | ||
RG-1671 | R-1671; RG-1671 | F. Hoffmann-La Roche Ltd | Details | ||
RO-7040547 | RG-7990; BIT-7201A; RO-7040547 | Genentech Inc, Novimmune Sa | Details | ||
Berdazimer sodium | NVN1000-SB206; MAP3-NONOate - SB-206; SB-019; NVN-1000-SB-206-Novan; SB-206 | Phase 3 Clinical | Novan Inc | Acne Vulgaris; Tinea Pedis; Psoriasis; Molluscum Contagiosum; Condylomata Acuminata; Dermatitis, Atopic | Details |
Lebrikizumab | RG-3637; TNX-650; Anti-IL-13; MILR-1444A; PRO-301444; RO-4909832; RO-5490255; DRM-06; R-3637 | Phase 3 Clinical | Genentech Inc | Idiopathic Pulmonary Fibrosis; Hodgkin Disease; Dermatitis; Skin Diseases; Asthma; Alzheimer Disease; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic; Eczema; Skin Diseases, Genetic | Details |
Cendakimab | RPC-4046; ABT-308; CC-93538 | Phase 3 Clinical | Abbott Laboratories | Eosinophilic gastroenteritis (EG); Eosinophilic Esophagitis; Asthma; Dermatitis, Atopic; Eczema | Details |
This web search service is supported by Google Inc.